Low participation in preventative health measures in a cohort of liver transplant recipients: A cross-sectional analysis.
neoplasms
organ transplantation
population surveillance
Journal
Clinical transplantation
ISSN: 1399-0012
Titre abrégé: Clin Transplant
Pays: Denmark
ID NLM: 8710240
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
revised:
20
01
2021
received:
23
08
2020
accepted:
13
02
2021
pubmed:
20
2
2021
medline:
6
7
2021
entrez:
19
2
2021
Statut:
ppublish
Résumé
Despite high rates of infection and malignancy post-solid organ transplant, there are little data on patient participation in preventative health care. We conducted a cross-sectional survey of post-liver transplant patients to evaluate insight into transplant-associated infective and neoplastic risks, and receipt of vaccination and cancer surveillance in accordance with Australian and local institution-specific guidelines. Descriptive analyses were used to assess characteristics potentially influencing adherence. Of 219 patients surveyed, adherence to bowel cancer surveillance was significantly reduced in those distant from transplantation compared with those recently transplanted (95.8% if transplanted ≤ 5 years ago vs. 68.3% if transplanted > 5 years ago, P < .001). Skin cancer surveillance participation with annual physician-directed examination was low (42.9%), particularly in younger patients (29.5% in < 50yo vs. 48.1% in ≥ 50yo, P = .01), who were also less adherent to vaccination recommendations (72.1% in < 50yo vs. 87.3% in ≥ 50yo, P = .008). This is the first analysis of preventative healthcare participation in a cohort of Australian liver transplant recipients, revealing concerning adherence to bowel and skin cancer surveillance recommendations. Major interventions to avoid preventable disease in this high-risk cohort are warranted.
Sections du résumé
BACKGROUND
Despite high rates of infection and malignancy post-solid organ transplant, there are little data on patient participation in preventative health care.
METHODS
We conducted a cross-sectional survey of post-liver transplant patients to evaluate insight into transplant-associated infective and neoplastic risks, and receipt of vaccination and cancer surveillance in accordance with Australian and local institution-specific guidelines. Descriptive analyses were used to assess characteristics potentially influencing adherence.
RESULTS
Of 219 patients surveyed, adherence to bowel cancer surveillance was significantly reduced in those distant from transplantation compared with those recently transplanted (95.8% if transplanted ≤ 5 years ago vs. 68.3% if transplanted > 5 years ago, P < .001). Skin cancer surveillance participation with annual physician-directed examination was low (42.9%), particularly in younger patients (29.5% in < 50yo vs. 48.1% in ≥ 50yo, P = .01), who were also less adherent to vaccination recommendations (72.1% in < 50yo vs. 87.3% in ≥ 50yo, P = .008).
CONCLUSIONS
This is the first analysis of preventative healthcare participation in a cohort of Australian liver transplant recipients, revealing concerning adherence to bowel and skin cancer surveillance recommendations. Major interventions to avoid preventable disease in this high-risk cohort are warranted.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14257Informations de copyright
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
McGuire BM, Rosenthal P, Brown CC, et al. Long-term management of the liver transplant patient: recommendations for the primary care doctor. Am J Transplant. 2009;9(9):1988-2003.
Seree O, Altieri M, Guillaume E, et al. Longterm risk of solid organ de novo malignancies after liver transplantation: a French national study on 11,226 patients. Liver Transpl. 2018;24(10):1425-1436.
Lucey MR, Terrault N, Ojo L, et al. Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl. 2013;19(1):3-26.
Compston JE. Osteoporosis after liver transplantation. Liver Transpl. 2003;9(4):321-330.
McCaughan GW, Munn SR. Liver transplantation in Australia and New Zealand. Liver Transpl. 2016;22(6):830-838.
Royal Australian College of General Practitioners, National Preventive and Community Medicine Committee. Guidelines for preventive activities in general practice. Aust Fam Physician. 2001;Spec No:S1i-xvi, S1-1-61.
Acuna SA, Huang JW, Scott AL, et al. Cancer screening recommendations for solid organ transplant recipients: a systematic review of clinical practice guidelines. Am J Transplant. 2017;17(1):103-114.
Cancer Council. Screening programs. About cancer 2016; https://www.cancer.org.au/about-cancer/early-detection/screening-programs/, 2020.
Australian Technical Advisory Group on Immunisation (ATAGI). Australian Immunisation Handbook. In. Canberra: Australian Government Department of Health; 2018.
Dharnidharka VR, Stablein DM, Harmon WE. Post-transplant infections now exceed acute rejection as cause for hospitalization: a report of the NAPRTCS. Am J Transplant. 2004;4(3):384-389.
Miao Y, Everly JJ, Gross TG, et al. De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population. Transplantation. 2009;87(9):1347-1359.
Finkenstedt A, Graziadei IW, Oberaigner W, et al. Extensive surveillance promotes early diagnosis and improved survival of de novo malignancies in liver transplant recipients. Am J Transplant. 2009;9(10):2355-2361.
Chak E, Saab S. Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review. Liver Int. 2010;30(9):1247-1258.
Acuna SA, Sutradhar R, Camacho X, et al. Uptake of cancer screening tests among recipients of solid organ transplantation. Am J Transplant. 2017;17(9):2434-2443.
Courtney AE, Leonard N, O'Neill CJ, McNamee PT, Maxwell AP. The uptake of cervical cancer screening by renal transplant recipients. Nephrol Dial Transplant. 2009;24(2):647-652.
Party CCACCGW. Clinical practice guidelines for the prevention, early detection and management of colorectal cancer. In: Cancer Council Australia Sydney; 2017.
Statistics ABo. Australian Statistical Geography Standard (ASGS): Volume 5-Remoteness Structure, Australia July 2011 (ABS Catalogue No. 1270.0. 55.005). In: Commonwealth of Australia Canberra; 2013.
Iannacone MR, Sinnya S, Pandeya N, et al. Prevalence of skin cancer and related skin tumors in high-risk kidney and liver transplant recipients in Queensland, Australia. J Invest Dermatol. 2016;136(7):1382-1386.
Jambusaria-Pahlajani A, Crow LD, Lowenstein S, et al. Predicting skin cancer in organ transplant recipients: development of the SUNTRAC screening tool using data from a multicenter cohort study. Transpl Int. 2019;32(12):1259-1267.
Iannacone MR, Pandeya N, Isbel N, et al. Sun protection behavior in organ transplant recipients in Queensland, Australia. Dermatology. 2015;231(4):360-366.
Pritchett EN, Doyle A, Shaver CM, et al. Nonmelanoma skin cancer in nonwhite organ transplant recipients. JAMA Dermatol. 2016;152(12):1348-1353.
National cancer screening programs participation data. Australian Institute of Health and Welfare; 2019. https://www.aihw.gov.au/reports/cancer-screening/national-cancer-screening-programs-participation/contents/breastscreen-australia. Accessed May 2019.
Hall IJ, Tangka FKL, Sabatino SA, Thompson TD, Graubard BI, Breen N. Patterns and trends in cancer screening in the United States. Prev Chronic Dis. 2018;15:E97.
Dyda A, Karki S, Hayen A, et al. Influenza and pneumococcal vaccination in Australian adults: a systematic review of coverage and factors associated with uptake. BMC Infect Dis. 2016;16(1):515.
Haagsma EB, Hagens VE, Schaapveld M, et al. Increased cancer risk after liver transplantation: a population-based study. J Hepatol. 2001;34(1):84-91.
Oey RC, van Tilburg L, Erler NS, et al. The yield and safety of screening colonoscopy in patients evaluated for liver transplantation. Hepatology. 2019;69(6):2598-2607.
Donate Life. Australian Donation and Transplantation Activity Report 2018. Canberra, Australia: Organ Tissue Authority; 14 February 2019.